Reports for RIVASTIGMINE

Ingredient

RIVASTIGMINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RIVASTIGMINE 4.5MG CAPSULE Resolved 2017-03-11 2017-05-18 487
APO-RIVASTIGMINE 4.5MG CAPSULE Resolved 2018-01-22 2018-01-22 36947
APO-RIVASTIGMINE 4.5MG CAPSULE Resolved 2018-01-22 2018-03-27 36949
APO-RIVASTIGMINE 4.5MG CAPSULE Resolved 2019-06-05 2019-10-07 85610
APO-RIVASTIGMINE 4.5MG CAPSULE Resolved 2025-01-23 2025-07-17 248492
APO-RIVASTIGMINE 6MG CAPSULE Resolved 2017-07-26 2018-03-27 17322
APO-RIVASTIGMINE 6MG CAPSULE Resolved 2019-07-03 2019-10-07 88360
APO-RIVASTIGMINE 6MG CAPSULE Resolved 2021-12-03 2021-12-13 150440
APO-RIVASTIGMINE 6MG CAPSULE Resolved 2024-09-20 2024-10-04 238239
APO-RIVASTIGMINE 6MG CAPSULE Resolved 2025-03-20 2025-07-17 253075

Showing 11 to 20 of 74

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ RIVASTIGMINE 3MG CAPSULE Discontinued 2024-12-10 2024-12-11 245273
SANDOZ RIVASTIGMINE 3MG CAPSULE Discontinued 2024-12-10 2024-12-11 245276
SANDOZ RIVASTIGMINE 4.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245279
SANDOZ RIVASTIGMINE 4.5MG CAPSULE Discontinued 2024-12-10 2024-12-11 245282
SANDOZ RIVASTIGMINE 6MG CAPSULE Discontinued 2024-12-10 2024-12-11 245291
SANDOZ RIVASTIGMINE 6MG CAPSULE Discontinued 2025-06-25 2025-06-26 261105

Showing 11 to 16 of 16